Pre-Operative PARPi and Irradiation (POPI) in Women With an Incomplete Response to Neo-Adjuvant Chemotherapy for Breast Cancer

Trial Profile

Pre-Operative PARPi and Irradiation (POPI) in Women With an Incomplete Response to Neo-Adjuvant Chemotherapy for Breast Cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Aug 2016

At a glance

  • Drugs Veliparib (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Aug 2016 Status changed from suspended to recruiting.
    • 12 Nov 2015 Status changed from recruiting to suspended, as reported by ClinicalTrials.gov.
    • 16 Aug 2013 Planned number of patients changed from 38 to 44 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top